According to various sources, the prevalence ranges from 0 to 11.8% in various populations
Vedolizumab, a humanized IgG1 monoclonal antibody that specifically targets the 47 integrin heterodimer without affecting 41, represents the prototypical gut-selective anti-trafficking agent approved by FDA, EMA, and PMDA based on the GEMINI trials demonstrating superior efficacy over placebo for both induction and maintenance in moderate to severe UC (GEMINI 1: 47.1% clinical response and 16.9% remission at week 6
If you take insulin or sulfonylureas alongside Mounjaro, be aware of the increased risk of hypoglycaemia and discuss with your healthcare team how this might affect activities such as driving
Orforglipron 36 mg: In ATTAIN-1, 11% weight loss was achieved, again well above Rybelsus outcomes
Overexpression of zinc-2-glycoprotein suppressed seizures and seizure-related neuroflammation in pentylenetetrazol-kindled rats
The patients in this trial were admitted to a trials unit with a possible change in their sleep patterns and diet that could have caused fluctuations in ALT
